Last reviewed · How we verify
sorbitan laurate
sorbitan laurate is a sorbitan laurate drug. It is currently in unknown development.
Unfortunately, the mechanism of action of sorbitan laurate is unknown.
Sorbitan laurate, also known as ARLACEL 60 or E-491, is a small molecule compound that is a mixture of esters formed from lauric acid and polyols derived from sorbitol. It is designated with the E number E493 and used as a food additive.
At a glance
| Generic name | sorbitan laurate |
|---|---|
| Drug class | sorbitan laurate |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
The mechanism of action of sorbitan laurate is not well understood, and it is unclear how it interacts with the body to produce its effects. Without more information, it is difficult to explain how it works or what it treats. Further research is needed to determine its pharmacological properties and clinical applications.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sorbitan laurate CI brief — competitive landscape report
- sorbitan laurate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about sorbitan laurate
What is sorbitan laurate?
How does sorbitan laurate work?
What drug class is sorbitan laurate in?
What development phase is sorbitan laurate in?
Related
- Drug class: All sorbitan laurate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing